Loading…

Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019–2020 targeted preventative mass campaigns

•Oral cholera vaccine (OCV) coverage in Goma urban area was 46.3 % two years post-campaign.•Micro-targeting of non-contiguous urban zones led to dilution of coverage.•Population movements and displacement created challenges for maintaining coverage.•Door to door strategies should account for people...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine: X 2024-10, Vol.20, p.100555, Article 100555
Main Authors: Briskin, Emily, Bateyi Mustafa, Stéphane Hans, Mahamba, Rachel, Kabunga, Deka, Kubuya, Janvier, Porten, Klaudia, Akilimali, Laurent, Okitayemba Welo, Placide, Broban, Anaïs
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3215-62ad19bdad6151650be0c779d6c587cd293d308cc0cb139d7ebf42fb6219b4d03
container_end_page
container_issue
container_start_page 100555
container_title Vaccine: X
container_volume 20
creator Briskin, Emily
Bateyi Mustafa, Stéphane Hans
Mahamba, Rachel
Kabunga, Deka
Kubuya, Janvier
Porten, Klaudia
Akilimali, Laurent
Okitayemba Welo, Placide
Broban, Anaïs
description •Oral cholera vaccine (OCV) coverage in Goma urban area was 46.3 % two years post-campaign.•Micro-targeting of non-contiguous urban zones led to dilution of coverage.•Population movements and displacement created challenges for maintaining coverage.•Door to door strategies should account for people being away during the day. In 2019–2020, preventative Oral Cholera Vaccine campaigns were conducted in 24/32 non-contiguous health areas of Goma, DR Congo. In August 2022, we measured coverage and factors potentially influencing success of the delivery strategy. We used random geo-sampled stratified cluster survey to estimate OCV coverage and assess population movement, diarrhea history, and reasons for non-vaccination. 603 households were visited. Coverage with at least one dose was 46.4 % (95 %CI: 41.8–51.0), and 50.1 % (95 %CI: 45.4–54.8) in areas targeted by vaccination compared to 26.3 % (95 %CI: 19.2–34.9) in non-targeted areas. Additionally, 7.0 % of participants reported moving from outside Goma since 2019, and 5.4 % reported history of severe diarrhea. Absence and unawareness were the main reasons for non-vaccination. Results suggest that targeting non-contiguous urban areas had a coverage-diluting effect. Targeting entire geographically contiguous areas, adapted distribution, and regular catch-up campaigns are operational recommendations to reach higher coverages arising from the study.
doi_str_mv 10.1016/j.jvacx.2024.100555
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_21662b992e9642848bc86e433e00463a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2590136224001281</els_id><doaj_id>oai_doaj_org_article_21662b992e9642848bc86e433e00463a</doaj_id><sourcerecordid>3108765651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3215-62ad19bdad6151650be0c779d6c587cd293d308cc0cb139d7ebf42fb6219b4d03</originalsourceid><addsrcrecordid>eNp9Uk1v1DAQjRCIVqW_AAn5yGF38UfsJAeE0AKlUqVKCM6WY0-yjpJ4sbMBblx77j_klzBtStVeOHk8fvNm5vll2UtGN4wy9abbdLOxPzec8hwzVEr5JDvmsqJrJhR_-iA-yk5T6iilnJWsVPnz7EhUgkkh1HF2dRlNT-wu9BANQUrrRyA2zHhtgfiRnIXBrMgHGIKNZvKWfIH9oe4xCA2ZdkC2YWzDiuAkfEWa0Pfhhx9bvLPqz-9rTFMymdjCBI7sI8wwTsgzAxlMSsSaYW98O6YX2bPG9AlO786T7Nunj1-3n9cXl2fn2_cXays4k2vFjWNV7YxTTDIlaQ3UFkXllJVlYR2vhBO0tJbamonKFVA3OW9qxbEqd1ScZOcLrwum0_voBxN_6WC8vk2E2GoTcc8eNGdK8bqqOFQq52Ve1rZUkAsBlOZKGOR6t3ChIgM4i6uhnI9IH7-MfqfbMGvGclbgByHD6zuGGL4fIE168MlC35sRwiFpwWhZKKkkQ6hYoDaGlCI0930Y1Tem0J2-NYW-MYVeTIFVrx6OeF_zzwIIeLsAAEWfPUSdrIfRgvMR7ISq-P82-Auymsiu</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3108765651</pqid></control><display><type>article</type><title>Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019–2020 targeted preventative mass campaigns</title><source>ScienceDirect</source><source>Open Access: PubMed Central</source><creator>Briskin, Emily ; Bateyi Mustafa, Stéphane Hans ; Mahamba, Rachel ; Kabunga, Deka ; Kubuya, Janvier ; Porten, Klaudia ; Akilimali, Laurent ; Okitayemba Welo, Placide ; Broban, Anaïs</creator><creatorcontrib>Briskin, Emily ; Bateyi Mustafa, Stéphane Hans ; Mahamba, Rachel ; Kabunga, Deka ; Kubuya, Janvier ; Porten, Klaudia ; Akilimali, Laurent ; Okitayemba Welo, Placide ; Broban, Anaïs ; Epicentre-MSF DRC cholera working group</creatorcontrib><description>•Oral cholera vaccine (OCV) coverage in Goma urban area was 46.3 % two years post-campaign.•Micro-targeting of non-contiguous urban zones led to dilution of coverage.•Population movements and displacement created challenges for maintaining coverage.•Door to door strategies should account for people being away during the day. In 2019–2020, preventative Oral Cholera Vaccine campaigns were conducted in 24/32 non-contiguous health areas of Goma, DR Congo. In August 2022, we measured coverage and factors potentially influencing success of the delivery strategy. We used random geo-sampled stratified cluster survey to estimate OCV coverage and assess population movement, diarrhea history, and reasons for non-vaccination. 603 households were visited. Coverage with at least one dose was 46.4 % (95 %CI: 41.8–51.0), and 50.1 % (95 %CI: 45.4–54.8) in areas targeted by vaccination compared to 26.3 % (95 %CI: 19.2–34.9) in non-targeted areas. Additionally, 7.0 % of participants reported moving from outside Goma since 2019, and 5.4 % reported history of severe diarrhea. Absence and unawareness were the main reasons for non-vaccination. Results suggest that targeting non-contiguous urban areas had a coverage-diluting effect. Targeting entire geographically contiguous areas, adapted distribution, and regular catch-up campaigns are operational recommendations to reach higher coverages arising from the study.</description><identifier>ISSN: 2590-1362</identifier><identifier>EISSN: 2590-1362</identifier><identifier>DOI: 10.1016/j.jvacx.2024.100555</identifier><identifier>PMID: 39315336</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Cholera ; Democratic Republic of the Congo ; Oral cholera vaccine ; Short communication ; Targeted vaccination ; Vaccine coverage survey</subject><ispartof>Vaccine: X, 2024-10, Vol.20, p.100555, Article 100555</ispartof><rights>2024 The Author(s)</rights><rights>2024 The Author(s).</rights><rights>2024 The Author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3215-62ad19bdad6151650be0c779d6c587cd293d308cc0cb139d7ebf42fb6219b4d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11417590/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2590136224001281$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,3535,27903,27904,45759,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39315336$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Briskin, Emily</creatorcontrib><creatorcontrib>Bateyi Mustafa, Stéphane Hans</creatorcontrib><creatorcontrib>Mahamba, Rachel</creatorcontrib><creatorcontrib>Kabunga, Deka</creatorcontrib><creatorcontrib>Kubuya, Janvier</creatorcontrib><creatorcontrib>Porten, Klaudia</creatorcontrib><creatorcontrib>Akilimali, Laurent</creatorcontrib><creatorcontrib>Okitayemba Welo, Placide</creatorcontrib><creatorcontrib>Broban, Anaïs</creatorcontrib><creatorcontrib>Epicentre-MSF DRC cholera working group</creatorcontrib><title>Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019–2020 targeted preventative mass campaigns</title><title>Vaccine: X</title><addtitle>Vaccine X</addtitle><description>•Oral cholera vaccine (OCV) coverage in Goma urban area was 46.3 % two years post-campaign.•Micro-targeting of non-contiguous urban zones led to dilution of coverage.•Population movements and displacement created challenges for maintaining coverage.•Door to door strategies should account for people being away during the day. In 2019–2020, preventative Oral Cholera Vaccine campaigns were conducted in 24/32 non-contiguous health areas of Goma, DR Congo. In August 2022, we measured coverage and factors potentially influencing success of the delivery strategy. We used random geo-sampled stratified cluster survey to estimate OCV coverage and assess population movement, diarrhea history, and reasons for non-vaccination. 603 households were visited. Coverage with at least one dose was 46.4 % (95 %CI: 41.8–51.0), and 50.1 % (95 %CI: 45.4–54.8) in areas targeted by vaccination compared to 26.3 % (95 %CI: 19.2–34.9) in non-targeted areas. Additionally, 7.0 % of participants reported moving from outside Goma since 2019, and 5.4 % reported history of severe diarrhea. Absence and unawareness were the main reasons for non-vaccination. Results suggest that targeting non-contiguous urban areas had a coverage-diluting effect. Targeting entire geographically contiguous areas, adapted distribution, and regular catch-up campaigns are operational recommendations to reach higher coverages arising from the study.</description><subject>Cholera</subject><subject>Democratic Republic of the Congo</subject><subject>Oral cholera vaccine</subject><subject>Short communication</subject><subject>Targeted vaccination</subject><subject>Vaccine coverage survey</subject><issn>2590-1362</issn><issn>2590-1362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9Uk1v1DAQjRCIVqW_AAn5yGF38UfsJAeE0AKlUqVKCM6WY0-yjpJ4sbMBblx77j_klzBtStVeOHk8fvNm5vll2UtGN4wy9abbdLOxPzec8hwzVEr5JDvmsqJrJhR_-iA-yk5T6iilnJWsVPnz7EhUgkkh1HF2dRlNT-wu9BANQUrrRyA2zHhtgfiRnIXBrMgHGIKNZvKWfIH9oe4xCA2ZdkC2YWzDiuAkfEWa0Pfhhx9bvLPqz-9rTFMymdjCBI7sI8wwTsgzAxlMSsSaYW98O6YX2bPG9AlO786T7Nunj1-3n9cXl2fn2_cXays4k2vFjWNV7YxTTDIlaQ3UFkXllJVlYR2vhBO0tJbamonKFVA3OW9qxbEqd1ScZOcLrwum0_voBxN_6WC8vk2E2GoTcc8eNGdK8bqqOFQq52Ve1rZUkAsBlOZKGOR6t3ChIgM4i6uhnI9IH7-MfqfbMGvGclbgByHD6zuGGL4fIE168MlC35sRwiFpwWhZKKkkQ6hYoDaGlCI0930Y1Tem0J2-NYW-MYVeTIFVrx6OeF_zzwIIeLsAAEWfPUSdrIfRgvMR7ISq-P82-Auymsiu</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Briskin, Emily</creator><creator>Bateyi Mustafa, Stéphane Hans</creator><creator>Mahamba, Rachel</creator><creator>Kabunga, Deka</creator><creator>Kubuya, Janvier</creator><creator>Porten, Klaudia</creator><creator>Akilimali, Laurent</creator><creator>Okitayemba Welo, Placide</creator><creator>Broban, Anaïs</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>202410</creationdate><title>Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019–2020 targeted preventative mass campaigns</title><author>Briskin, Emily ; Bateyi Mustafa, Stéphane Hans ; Mahamba, Rachel ; Kabunga, Deka ; Kubuya, Janvier ; Porten, Klaudia ; Akilimali, Laurent ; Okitayemba Welo, Placide ; Broban, Anaïs</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3215-62ad19bdad6151650be0c779d6c587cd293d308cc0cb139d7ebf42fb6219b4d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cholera</topic><topic>Democratic Republic of the Congo</topic><topic>Oral cholera vaccine</topic><topic>Short communication</topic><topic>Targeted vaccination</topic><topic>Vaccine coverage survey</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Briskin, Emily</creatorcontrib><creatorcontrib>Bateyi Mustafa, Stéphane Hans</creatorcontrib><creatorcontrib>Mahamba, Rachel</creatorcontrib><creatorcontrib>Kabunga, Deka</creatorcontrib><creatorcontrib>Kubuya, Janvier</creatorcontrib><creatorcontrib>Porten, Klaudia</creatorcontrib><creatorcontrib>Akilimali, Laurent</creatorcontrib><creatorcontrib>Okitayemba Welo, Placide</creatorcontrib><creatorcontrib>Broban, Anaïs</creatorcontrib><creatorcontrib>Epicentre-MSF DRC cholera working group</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Vaccine: X</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Briskin, Emily</au><au>Bateyi Mustafa, Stéphane Hans</au><au>Mahamba, Rachel</au><au>Kabunga, Deka</au><au>Kubuya, Janvier</au><au>Porten, Klaudia</au><au>Akilimali, Laurent</au><au>Okitayemba Welo, Placide</au><au>Broban, Anaïs</au><aucorp>Epicentre-MSF DRC cholera working group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019–2020 targeted preventative mass campaigns</atitle><jtitle>Vaccine: X</jtitle><addtitle>Vaccine X</addtitle><date>2024-10</date><risdate>2024</risdate><volume>20</volume><spage>100555</spage><pages>100555-</pages><artnum>100555</artnum><issn>2590-1362</issn><eissn>2590-1362</eissn><abstract>•Oral cholera vaccine (OCV) coverage in Goma urban area was 46.3 % two years post-campaign.•Micro-targeting of non-contiguous urban zones led to dilution of coverage.•Population movements and displacement created challenges for maintaining coverage.•Door to door strategies should account for people being away during the day. In 2019–2020, preventative Oral Cholera Vaccine campaigns were conducted in 24/32 non-contiguous health areas of Goma, DR Congo. In August 2022, we measured coverage and factors potentially influencing success of the delivery strategy. We used random geo-sampled stratified cluster survey to estimate OCV coverage and assess population movement, diarrhea history, and reasons for non-vaccination. 603 households were visited. Coverage with at least one dose was 46.4 % (95 %CI: 41.8–51.0), and 50.1 % (95 %CI: 45.4–54.8) in areas targeted by vaccination compared to 26.3 % (95 %CI: 19.2–34.9) in non-targeted areas. Additionally, 7.0 % of participants reported moving from outside Goma since 2019, and 5.4 % reported history of severe diarrhea. Absence and unawareness were the main reasons for non-vaccination. Results suggest that targeting non-contiguous urban areas had a coverage-diluting effect. Targeting entire geographically contiguous areas, adapted distribution, and regular catch-up campaigns are operational recommendations to reach higher coverages arising from the study.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>39315336</pmid><doi>10.1016/j.jvacx.2024.100555</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2590-1362
ispartof Vaccine: X, 2024-10, Vol.20, p.100555, Article 100555
issn 2590-1362
2590-1362
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_21662b992e9642848bc86e433e00463a
source ScienceDirect; Open Access: PubMed Central
subjects Cholera
Democratic Republic of the Congo
Oral cholera vaccine
Short communication
Targeted vaccination
Vaccine coverage survey
title Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019–2020 targeted preventative mass campaigns
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T01%3A33%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20cholera%20vaccine%20coverage%20in%20Goma,%20Democratic%20Republic%20of%20the%20Congo,%202022,%20following%202019%E2%80%932020%20targeted%20preventative%20mass%20campaigns&rft.jtitle=Vaccine:%20X&rft.au=Briskin,%20Emily&rft.aucorp=Epicentre-MSF%20DRC%20cholera%20working%20group&rft.date=2024-10&rft.volume=20&rft.spage=100555&rft.pages=100555-&rft.artnum=100555&rft.issn=2590-1362&rft.eissn=2590-1362&rft_id=info:doi/10.1016/j.jvacx.2024.100555&rft_dat=%3Cproquest_doaj_%3E3108765651%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3215-62ad19bdad6151650be0c779d6c587cd293d308cc0cb139d7ebf42fb6219b4d03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3108765651&rft_id=info:pmid/39315336&rfr_iscdi=true